Search

Search Constraints

You searched for: Author/Creator O'Malley, D.

Search Results

1. 197TiP First-in-human (FIH) phase I/II study of ubamatamab, a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer (OC). (December 2022)

8. Extracting Hydrocarbon From Shale: An Investigation of the Factors That Influence the Decline and the Tail of the Production Curve. Issue 5 (24th May 2018)